Estimated Read Time:

1 minute

SABCS Snippets: Results from the AFT-38 PATINA trial

Lisa Anne Carey, MD, talks with Otto Metzger, MD, about the results of the phase 3 PATINA trial, which evaluated the efficacy and safety of palbociclib + anti-HER2 therapy + endocrine therapy vs. anti-HER2 therapy after induction treatment for hormone receptor-positive (HR+)/HER-positive metastatic breast cancer.

Share


Recent Posts